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Abstract
In tissue engineering, endochondral ossification (EO) is often replicated by chondrogenically differentiating 
mesenchymal stromal cells (MSCs) in vitro and achieving bone formation through in vivo implantation. 
The resulting marrow-containing bone constructs are promising as a treatment for bone defects. However, 
limited bone formation capacity has prevented them from reaching their full potential. This is further 
complicated since it is not fully understood how this bone formation is achieved. Acellular grafts derived 
from chondrogenically differentiated MSCs can initiate bone formation; however, which component within 
these decellularised matrices contribute to bone formation has yet to be determined. Collagen type X (COLX), 
a hypertrophy-associated collagen found within these constructs, is involved in matrix organisation, calcium 
binding and matrix vesicle compartmentalisation. However, the importance of COLX during tissue-engineered 
chondrogenesis and subsequent bone formation is unknown. The present study investigated the importance of 
COLX by shRNA-mediated gene silencing in primary MSCs. A significant knock-down of COLX disrupted the 
production of extracellular matrix key components and the secretion profile of chondrogenically differentiated 
MSCs. Following in vivo implantation, disrupted bone formation in knock-down constructs was observed. 
The importance of COLX was confirmed during both chondrogenic differentiation and subsequent EO in 
this tissue engineering setting.
Keywords: Collagen type X, endochondral ossification, regenerative medicine, bone tissue engineering, 
mesenchymal stem cells, chondrogenesis.
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Introduction
Endochondral ossification (EO) is the process by 
which long bones are formed. It relies on mesenchymal 
cells, which condense and undergo chondrogenic 
differentiation, resulting in the formation of a 
cartilage anlage (Ornitz, 2005). Subsequently, this 
anlage is remodelled by osteoclasts (Ortega et al., 
2004), invaded by nearby vasculature (Maes et al., 
2010) and, ultimately, serves as the template for 
bone formation by osteoblasts (Mackie, 2003). EO 
can be mimicked in a tissue engineering setting by 
chondrogenically differentiating mesenchymal stem 
cells (MSCs) pre-implantation (Farrell et al., 2011; 
Farrell et al., 2008; Scotti et al., 2013; Scotti et al., 2010; 
van der Stok et al., 2014). Although in the future such 
grafts could offer an attractive alternative to currently 
available treatment options, these constructs exhibit 
variable degrees of bone formation, with variable 
success in large-defect repair, depending on the 
approach used (Knuth et al., 2017; van der Stok et 
al., 2014). In recent years, the importance of donor 
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cells in experimental models has been identified, 
as they are capable of directly contributing to bone 
formation. There is evidence suggesting that, during 
development (Cervantes-Diaz et al., 2017; Yang et al., 
2014; Zhou et al., 2014), implanted cells can directly 
contribute to osteoblast-like cell populations (Bahney 
et al., 2014; Scotti et al., 2010). However, there is 
still much to learn about these grafts. Recently, 
it has been shown that devitalised grafts derived 
from chondrogenic MSCs form endochondral bone 
following in vivo implantation (Bourgine et al., 2014; 
Cunniffe et al., 2015), indicating that components 
within the chondrogenic matrix itself are capable of 
inducing bone formation independent of the presence 
of MSCs. Cunniffe et al. (2015) further showed that 
biomaterials containing decellularised matrices, 
specifically those originating from hypertrophic 
chondrogenically differentiated MSCs, are far 
better at inducing this bone formation than non-
hypertrophic counterparts. However, what exactly 
within these hypertrophic matrices is responsible for 
this difference remains to be determined.
 During chondrogenic differentiation, collagen 
type X (COLX), the major marker of hypertrophic 
chondrocytes, can be detected within the first 
few days (Knuth et al., 2017; Pelttari et al., 2006). 
Developmental ly,  fol lowing hypertrophic 
differentiation, the extracellular matrix (ECM) is 
remodelled to allow for invasion of the template 
by the nearby vasculature (Bahney et al., 2015; 
Colnot and Helms, 2001). Next, mineralisation 
of the cartilage template is initiated, osteoclastic 
remodelling occurs throughout the process of matrix 
remodelling, allowing for easier cell migration 
and vascularisation to occur (Colnot and Helms, 
2001; Engsig et al., 2000; Touaitahuata et al., 2014), 
and, ultimately, endochondral bone formation 
takes place (Colnot and Helms, 2001; Deckers 
et al., 2002). COLX is produced by hypertrophic 
chondrocytes (HCs) and comprises more than 
45 % of the total collagens produced (Luvalle et al., 
1992). It plays several important roles during EO, 
even contributing to the structural support of the 
pericellular network (Schmid and Linsenmayer, 
1985; Shen, 2005), support that is essential during 
matrix remodelling (Shen, 2005). Additionally, 
COLX may play a role in initiating biomineralisation 
by binding annexin V (Kirsch and Pfäffle, 1992; 
Wu et al., 1991). Annexin V facilitates the influx of 
Ca2+ into matrix vesicles, initiating mineralisation 
(Anderson et al., 2005). Others have hypothesised 
that COLX is also essential for the proper distribution 
of collagens and proteoglycans throughout the 
ECM (Chan and Jacenko, 1998; Jacenko et al., 2001), 
further supporting a role of COLX in proper matrix 
organisation. However, these hypotheses have 
been hard to verify since previous studies utilising 
transgenic (Tg) mouse models in which COLX is 
removed, truncated or disrupted using different 
methods produce conflicting data (Campbell et al., 
2004; Jacenko et al., 2001; Kim et al., 2003; Kwan et al., 
1997; Rosati et al., 1994). Some groups have shown 
early developmental irregularities attributed to a 
lack of COLX, including perinatal death, dwarfism 
and various skeletal abnormalities (Campbell et al., 
2004; Jacenko et al., 2001). Rosati et al. (1994) reported 
a complete absence of phenotypic changes. Studies 
have also reported that a lack of COLX results in a 
compromised immune system, with an inability to 
elicit and control a proper immune reaction (Jacenko 
et al., 2002; Sweeney et al., 2008; Sweeney et al., 2010), 
while others find no such deficiency (Rosati et al., 
1994). These different findings could come down to 
the genetic variation among different strains of mice 
used, variation in the methodology used to achieve 
knock-down/interference of COLX or differences in 
sample processing, analysis or staining techniques. 
Nevertheless, this makes understanding the role 
COLX increasingly challenging. Furthermore, COLX 
has only been studied from a developmental stand 
point. How COLX contributes to both chondrogenic 
differentiation of MSCs and subsequent endochondral 
bone formation has not been studied. The goal of the 
present study was to determine if COLX is essential 
for MSC-mediated chondrogenic differentiation and 
subsequent endochondral bone formation. COL10A1 
expression was knocked-down using a lentivirus-
delivered short hairpin RNA (shRNA) directed 
against COL10A1 mRNA sequence. In this way, it was 
possible to specifically knock-down the production 
of COLX in MSCs and determine its contribution to 
tissue engineered chondrogenesis and endochondral 
bone formation. COL10A1 knock-down resulted in 
disrupted chondrogenic differentiation. When the 
knock-down was highly efficient, the production 
of key ECM components was severely decreased. 
Several secreted factors linked to the recruitment 
of key cell types involved in EO were also down-
regulated. Following in vivo implantation, EO was 
likewise affected. However, this was only observed 
when knock-down efficiency was more than 80 %, 
indicating that a minimal production of COL10A1 
was sufficient to prevent these adverse effects. The 
study showed the importance of COLX in MSC-
mediated chondrogenesis and EO, furthering the 
understanding of tissue-engineered endochondral 
bone formation.
Materials and Methods
MSC culture
MSCs were isolated from leftover material obtained 
from patients undergoing alveolar bone graft surgery 
(Medical Ethical Testing Commission approval 
code 2014-106; donor age range: 8-12 years old) 
following parental consent in accordance with 
relevant guidelines and regulations, as previously 
described (Knuth et al., 2018). Cells were plated 
at approximately 2,300 cells/cm2 at 37 °C and 
5 % CO2 in a humidified atmosphere in complete 
expansion medium [alpha modification minimum 
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essential medium (αMEM; Gibco) containing 10 % 
foetal bovine serum (41Q204K; Gibco), 50 μg/mL 
gentamycin (Thermo Fisher Scientific), 1.5 μg/mL 
fungizone (Thermo Fisher Scientific), 25 μg/mL 
L-ascorbic acid 2-phosphate (Sigma-Aldrich) and 
1 ng/mL fibroblast growth factor-2 (Instruchemie, 
Delfzijl, the Netherlands)]. Medium was replenished 
every 3-4 d until cells reached approximately 90 % 
confluency. Then, they were passaged using 0.05 % 
trypsin. Donor 1 and 2 were transdifferentiated 
following passage 6 and donor 3 was used at passage 
7. At each passage, cells performed approximately 
3 population doublings, with no difference among 
donors (data not shown). Population doublings were 
calculated by determining the log2 of the total cell 
number following growth for one passage, divided 
by the initial population count.
Lentiviral generation
MISSION® TRC1.5 shRNA targeting COL10A1 
mRNA (TRCN0000082798; Sigma-Aldrich) and 
control plasmids [SHC001 (empty vector) and 
SHC002 (non-target control); Sigma-Aldrich] were 
transformed into DH5-α Escherichia coli (Invitrogen). 
shRNA targeting COL10A1 mRNA was analysed 
using the basic local alignment search tool on 
the NCBI website and no sequence homology 
with any other gene was identified. Likewise, no 
human homology was found for the non-target 
plasmid. Plasmids were isolated using an EndoFree 
Plasmid Maxi Kit (QIAGEN) as per manufacturer’s 
instructions. HEK293FT cells were expanded in 
complete HEK medium [high-glucose Dulbecco’s 
modified Eagle medium (DMEM; Gibco), 10 % foetal 
bovine serum, 50 μg/mL gentamycin, 1.5 μg/mL 
fungizone] supplemented with 50 μg/mL geneticin 
(Thermo Fisher Scientific) and maintained at 37 °C 
and 5 % CO2 in a humidified atmosphere. 24 h prior 
to transfection, 3 × 105 cells/cm2 were plated in tissue 
culture Petri dishes (Corning) in high-glucose DMEM 
containing 10 % foetal bovine serum. Cells were 
co-transfected with plasmids by calcium phosphate 
precipitation [3 μg pLP1 plasmid, 3 μg pLP2 plasmid, 
3 μg pLP/VSVG plasmid (ViraPower Lentiviral 
Packaging Mix, Thermo Fisher Scientific) and 7.5 μg 
shRNA plasmid]. Medium was refreshed 24 h post 
transfection with HEK medium containing 20 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES). Viral supernatant was harvested and 
filtered (0.45 μm filter) 48 h following transfection 
and stored at − 80 °C until use. p24 concentration was 
determined using INNOTEST® HIV Antigen mAb 
enzyme immunoassay (Fujirebio, Gent, Belgium) 
performed as per manufacture’s instruction.
Lentiviral transduction
MSCs were transduced at 30 % confluency. Cells were 
incubated for 48 h with 40 or 60 ng/mL p24 particles 
(depending on the batch used and the optimal dose 
determined by titration experiments) and 20 μg/mL 
protamine sulphate (Sigma-Aldrich) in complete 
expansion medium (Fig. 1-3). Following incubation, 
cells were washed, expanded and selected after 
reaching 80 % confluency. Selection was achieved 
in 72 h using 5 μg/mL puromycin in complete 
expansion medium. After selection, cells were 
washed and expanded until 90 % confluency, when 
they were either harvested for RNA [homogenised in 
350 μL Trizol (Thermo Fisher Scientific) and stored 
at − 80 °C until isolated] or used for differentiation 
studies. p24 particle, protamine sulphate and 
puromycin concentrations were determined prior 
to experimental start through titration experiments 
(Fig. 1-3). Knock-down percentage was calculated 
by subtracting the average COL10A1 expression 
in COL10A1 knock-down pellets from the average 
COLX expression in non-treated pellets. This was 
divided by the average of the non-treated COL10A1 
expression and then multiplied by 100 to obtain a 
percentage.
Chondrogenic differentiation
MSCs were chondrogenically differentiated in 
complete chondrogenic medium [high-glucose 
DMEM supplemented with 50 μg/mL gentamycin, 
1.5 μg/mL fungizone, 1 mM sodium pyruvate (Gibco), 
40 μg/mL proline (Sigma-Aldrich), 1 : 100 v/v insulin-
transferrin-selenium (ITS+; BD Biosciences), 10 ng/
mL transforming growth factor β3 (Peprotech), 
25 μg/mL L-ascorbic acid 2-phosphate and 100 nM 
dexamethasone (Sigma-Aldrich)] using 2 × 105 MSCs 
resuspended in 15 mL polypropylene tubes and 
centrifuged at 300 ×g for 8 min. Cultures were 
maintained in a humidified atmosphere at 37 °C 
and 5 % CO2 and medium was replenished every 
3-4 d for 21 d. Samples were harvested following 7 
and 21 d in culture for RNA isolation (as previously 
described), glycosaminoglycan (GAG)/DNA analysis 
(stored at − 80 °C), Western blot (snap-frozen), 
histology (4 % formalin fixed for 2 h), enzyme-linked 
immunosorbent assay (ELISA) (supernatant) or 
migration (conditioned medium; described below).
Osteogenic differentiation
MSCs were plated at a density of 3 × 103 cells/cm2 in 
expansion medium. 24 h after plating, the medium 
was changed to osteogenic induction medium 
(high-glucose DMEM supplemented with 10 % 
v/v foetal bovine serum, 50 μg/mL gentamycin, 
1.5 μg/mL fungizone, 10 mM glycerol-3-phosphate, 
0.1 μM dexamethasone and 0.1 mM L-ascorbic acid 
2-phosphate). Cultures were maintained at 37 °C and 
5 % CO2 in a humidified atmosphere. Medium was 
refreshed every 3-4 d for 13-21 d. Once cell sheets 
began to detach from the well outer periphery, 
culture was ended and samples were fixed in 4 % 
(w/v) formalin. von Kossa staining was performed 
as previously described (Knuth et al., 2018).
Adipogenic differentiation
MSCs were plated at a density of 2.1 × 104 cells/
cm2 in adipogenic induction medium [high-glucose 
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DMEM supplemented with 10 % foetal bovine 
serum, 50 μg/mL gentamycin, 1.5 μg/mL fungizone, 
0.2 mM indomethacin (Sigma-Aldrich), 0.01 mg/mL 
insulin (Sigma-Aldrich), 0.5 mM 3 iso-butyl-1-methyl-
xanthine (Sigma-Aldrich) and 1 μM dexamethasone]. 
Cultures were maintained at 37 °C and 5 % CO2 in a 
humidified atmosphere. Medium was refreshed as 
every 3-4 d for 19-21 d. Then, samples were prepared 
for histology [4 % (w/v) formalin-fixed]. Oil red O 
staining was performed as previously described 
(Knuth et al., 2018).
Cell viability testing
MSCs were plated at a density of 2.1 × 104 cells/cm2 
and treated for 48 h at 37 °C, 5 % CO2 in a humidified 
atmosphere with either protamine sulphate (10, 
25, 50, 75 or 100 μg/mL) or puromycin (1.25, 2.5, 
5, 7.5 or 10 μg/mL) in MSC expansion medium. 
Then, cells were washed with phosphate-buffered 
saline (PBS) and incubated in the dark for 3 h at 
37 °C and 5 % CO2 in a humidified atmosphere in 
0.5 mg/mL MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide; Sigma-Aldrich)-
supplemented MSC expansion medium. Next, 
medium was aspirated and cells were washed with 
PBS. MTT-tetrazolium crystals formed by healthy 
cells were dissolved in 100 % ethanol. Absorbance 
was measured at 570 nm and 670 nm; 570 : 670 ratio 
was compared to non-treated control MSCs.
Western blot
Pellets were snap-frozen in liquid nitrogen and 
homogenised in 100 μL M-PER (Mammalian Protein 
Extraction Reagent, Thermo Fisher Scientific) with 1× 
Halt™ Protease Inhibitor Cocktail (Thermo Fisher 
Scientific) followed by water bath sonication (10 
cycles of 30 s sonication and 30 s rest). Total protein 
was measured using the Pierce™ BCA Protein 
Assay Kit (Thermo Fisher Scientific). 10 μg total 
protein was incubated at 95 °C and separated on 
a gradient gel (Bolt 4-12 % Bis-Tris Plus, Thermo 
Fisher Scientific) under non-reducing conditions. 
Proteins were transferred to a polyvinylidene 
fluoride or polyvinylidene difluoride (PVDF) 
membrane and blocked with 5 % w/v fat-free milk 
in 0.1 % v/v tris-buffered saline (TBS)-Tween 20. The 
membrane was cut at 70 kDa and each piece was 
incubated overnight with its respective antibody: 
1 : 1,000 mouse monoclonal anti-COLX, clone X53 
(Quartett, Berlin, Germany) and 1 : 2,000 rabbit 
monoclonal anti α-tubulin (Cell Signaling). Next, 
incubation for 1 h at room temperature with the 
respective secondary antibody was performed: 
1 : 2,000 horseradish peroxidase (HRP)-conjugated 
goat anti-mouse and 1 : 2,000 HRP-conjugated goat 
anti-rabbit (both Thermo Fisher Scientific). Protein 
bands were visualised using the Super Signal West 
detection kit (Thermo Fisher Scientific) on the digital 
Δcamera Alliance 2.7 (Uvitec, Cambridge, UK) with 
an exposure time of 15 (COLX) or 17 min (μ-tubulin).
RNA isolation and gene expression
Samples were homogenised in 350 μL Trizol to which 
70 μL 100 % chloroform was added and thoroughly 
mixed. Following a 10 min incubation at room 
temperature and phase separation at 10,000 ×g for 
15 min, the aqueous phase was mixed with an equal 
volume of 70 % ethanol and transferred onto an 
RNeasy® kit column. RNA was isolation and purified 
using the RNeasy® Micro Kit (QIAGEN) following 
manufacturer’s instructions. cDNA was reverse-
transcribed as per manufacturer’s instruction using 
a First Strand cDNA Synthesis Kit (Thermo Fisher 
Scientific) and PCR was performed as previously 
described (Table 1) (Knuth et al., 2015. Mesenchymal 
stem cell-mediated endochondral ossification 
utilising micropellets and brief chondrogenic 
priming, towards scale-up. Proceedings of the 24th 
NBTE Annual Meeting, Lunteren, The Netherlands. 
pp: 65). For gene expression of monolayer, day 7 and 
day 14 of chondrogenic differentiation, 3 different 
MSC donors were analysed. For gene expression at 
day 21, only one MSC donor was analysed (3 pellets/
donor/condition). Gene expression is shown as ΔΔCT.
Biochemical assay
Chondrogenically differentiated samples stored 
at − 80°C were digested overnight at 60 °C in 
buffer containing papain [0.2  M NaH2PO4, 
0.01 M ethylenediaminetetraacetic acid (EDTA), 
Table 1. Primer sequences used for real time PCR. B2M: beta-2-microglobulin; VEGFa: vascular endothelial 
growth factor a; COL1A1: collagen type I; COL2A1: collagen type II; COL10A1: collagen type X; BMP2: 
bone morphogenetic protein 2; MMP13: matrix metallopeptidase 13; AGCN: aggrecan.
Gene names Forward sequence (5’-3’) Reverse sequence (5’-3’)
B2M TGCTCGCGCTACTCTCTCTTT TCTGCTGGATGACGTGAGTAAAC
VEGFa CTTGCCTTGCTGCTCTACC CACACAGGATGGCTTGAAG
COLIA1 CAGCCGCTTCACCTACAGC TTTTGTATTCAATCACTGTCTTGCC
COL2A1 CCCCATCTGCCCAACTGA CTCCTTTCTGTCCCTTTGGT
COL10A1 ACTTCTCTTACCACATACACG CCAGGTAGCCCTTGATGATGTACT
BMP2 AACACTGTGCGCAGCTTCC CTCCGGGTTGTTTTCCCAC
MMP13 AAGGAGCATGGCGACTTCT TGGCCCAGGAGGAAAAGC
AGCN TCGAGGACAGCGAGGCC TCGAGGGTGTAGCGTGTAGAGA
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were implanted subcutaneously (conditions were 
randomised among mice and physical positions). 
3 implantations were performed per experimental 
condition (3 pellets or 600,000 cells/implantation). 
Incisions were closed using staples. Animals were 
euthanised 8 or 10 weeks post implantation by CO2 
asphyxiation.
X-ray micro-computed tomography (μCT) 
longitudinal imaging
μCT scans were performed at the Applied Molecular 
Imaging Erasmus MC facility using the Quantum FX 
(Perkin-Elmer). While animals were anaesthetised (1-
2.5 % isoflurane), scans were acquired using a field 
of view of 60 mm (90 kV/160 mA, 4.5 min) bi-weekly. 
Using the Analyze 11.0 software (AnalyzeDirect, 
Nieuwe Niedorp, the Netherlands), scans were 
quantified by converting original linear attenuation 
coefficient measurements by linear transformation 
to Hounsfield units (HU). Median spatial filters 
were applied with a 3 × 3 × 3 kernel size. Values 
corresponding to a density of over 0.133 g/cm3 
(determined by phantom scans) were segmented out 
and quantified as calcified tissue.
Figures and statistical analysis
Graph figures were created using GraphPad Software 
(La Jolla, CA, USA). Graphs depict ΔCT values (Livak 
and Schmittgen, 2001), setting non-treated value 
to 1. Linear mixed model with Bonferroni post-hoc 
comparison was performed using SPSS (Ver 21. SPSS 
Inc) on expansion data in Fig. 1.
Results
Lentivirally transduced MSCs maintain proliferative 
and differentiation capacity following puromycin 
selection
Concentrations of protamine sulphate (20 ng/mL) and 
puromycin (5 μg/mL) were optimised by titration 
experiments (data not shown). Protamine sulphate 
was used to aid trafficking of the lentivirus particles 
into the cell by neutralising the charge between the 
MSC membrane and viral envelope. Puromycin 
was used to select only transduced cells due to the 
presence of a puromycin resistance cassette in the 
lentivirus. Cells not containing the cassette, meaning 
non-transduced cells, were killed in the presence of 
puromycin. Minimal doses of both drugs were chosen 
to avoid unnecessary cell stress during transduction. 
For each viral batch, the optimal concentration (as 
determined by p24 viral antigen concentration) was 
determined based on minimum dose at which cells 
maintained proliferative capacity (compared to non-
transduced controls from the same donor) following 
selection. Following transduction with optimal 
lentiviral and protamine sulphate concentrations, 
MSCs maintained a healthy spindle-like morphology, 
which was retained after puromycin selection (data 
not shown). MSCs recovered quickly from selection 
0.01 M cysteine HCl, 250 μg/mL papain (Sigma-
Aldrich), pH 6]. Then, GAGs were quantified 
by dimethylmethylene blue assay (pH 3) with 
chondroitin sulphate C (Sigma-Aldrich) as a 
standard, utilising an absorbance 530 : 590 ratio. 
Ethidium bromide was used to determine sample 
DNA content. Calf thymus DNA (Sigma-Aldrich) 
was used as a standard.
Cytokine quantification
Culture medium was refreshed 24 h before harvesting 
the pellets. Supernatant was applied to a human 
cytokine angiogenic multiplex chemiluminescent 
ELISA (150251HU; Quansys Biosciences, Logan, 
UT, USA) as per manufacturer’s instructions. 
This angiogenic multiplex included the following 
targets: angiotensin II (Ang-2), fibroblast growth 
factor-2 (FGF-2), hepatocyte growth factor (HGF), 
interleukin-8 (IL-8), platelet derived growth factor-
BB (PDGF-BB), tissue inhibitor of metalloproteinase 
1 and 2 (TIMP-1 and TIMP-2), tumour necrosis 
factor (TNF). The ELISA plate was imaged using the 
Amersham Imager 600 (GE Healthcare) and images 
were quantified using the Q-view software® provided 
by the ELISA manufacturer (Quansys Bioscience).
Histology
In vitro samples were fixed for 2 h in 4 % formalin 
prior to paraffin-wax embedding. In vivo samples 
were formalin-fixed for 24 h and decalcified for 
10 d in 10 % EDTA w/v in H2O refreshed every 
other day. Following paraffin-wax embedding, 
6 μm-thick sections were cut from all samples. 
Sections were deparaffinised and stained with 
haematoxylin-eosin (H&E), safranin O, tartrate-
resistant acid phosphatase (TRAP) and antibodies 
against COLII or COLX, as previously described 
(Knuth et al., 2015. Mesenchymal stem cell-mediated 
endochondral ossification utilising micropellets 
and brief chondrogenic priming, towards scale-up. 
Proceedings of the 24th NBTE Annual Meeting, 
Lunteren, The Netherlands. pp: 65).
Subcutaneous implantation
Experiments were conducted with approval by the 
Animal Experiments Committee at the Erasmus 
Medical Centre, Rotterdam (EU license number 
15-114-02) adhering to all relevant guidelines 
and regulations. 8 week-old athymic nude mice 
(Balb/c nudes, Charles River) were housed under 
standard light-dark cycles with food and water ad 
libitum (12 mice in total; housed in groups of 2). 
Pain medication (buprenorphine 0.05 mg/kg body 
weight) was administered pre-operatively under 
anaesthesia (1-3 % isoflurane). Dorsal incisions were 
created in which a subcutaneous pocket was made. 
4 subcutaneous pockets were created in the back of 
each mouse through two incisions, one in the upper 
and one in lower back. At each incision, 2 pockets 
(left and right) were created by blunt dissection. 
3 control or virally transduced pellets per pocket 
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stress and all grew at a similar rate, undergoing 
comparable population doublings as non-treated 
controls (Fig. 1a,b). Furthermore, transduced cells 
maintained their differentiation potential upon 
osteogenic and adipogenic induction (Fig. 1c). 
Chondrogenesis as well as hypertrophy was observed 
by day 7 as evidenced by a clear upregulation in 
COL2A1, COL10A1 and COL1A1 expression (Fig. 
1d). The expression of COL2A1 and COL10A1 was 
strongly affected by COL10A1 knock-down (Fig. 1d).
COL10A1 could be efficiently knocked-down by 
lentivirally delivered shRNA
MSCs from each condition were chondrogenically 
differentiated for 21 d by pellet culture. Following 
differentiation, COL10A1 expression was effectively 
knocked-down with an efficiency ranging between 
80 and 99 %, depending on the MSC donor (Fig. 
2a; donor 1: > 99 %; donor 2: 99 %; donor 3: 80 %). 
Gene and protein expressions of COLX were 
significantly downregulated as compared to non-
Fig. 1. Lentiviral infection did not hinder MSC expansion or differentiation capabilities. (a) MSCs were 
transduced with lentivirus containing an empty vector, non-target shRNA or COL10A1 shRNA. Then, 
MSCs were selected based on puromycin resistance. Following transduction, cells maintained MSC-like 
morphology. Post-selection, positively infected cells maintained both morphology and proliferative capacity; 
scale bar: 200 μm. (b) Transduced MSCs post-selection expanded at a similar rate to non-treated MSCs, 
undergoing a similar number of population doublings (n = 4; linear mixed model with Bonferroni post-hoc 
comparison: non-significant). (c) Transduced MSCs maintained the capacity to differentiate osteogenically 
and adipogenically. Scale bar: 50 μm. (d) mRNA expression of COL10A1, COL1A1 and COL2A1 following 
7 d of chondrogenic differentiation in donor 1. NT: non-treated; EV: empty vector; SC: non-target control; 
KD: knock-down. 
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treated, empty vector and non-target controls, 
which exhibited normal expression levels for all 
donors (Fig. 2a-c). COLX downregulation was 
confirmed by immunohistochemistry and Western 
blot for all donors and, therefore, both virus batches 
used (Fig. 2b,c). COL10A1 knock-down pellets 
from donor 1 were too small to be processed for 
immunohistochemistry (Fig. 2c; donor 1). A complete 
absence of positive staining in COL10A1 knock-down 
pellets from donor 2 and a slight positivity in the 
pellets from donor 3 were observed; however, the 
quantity was far less than that observed in controls 
(Fig. 2c; donor 2, donor 3). Overall, the validity of 
the silencing approach was demonstrated at both 
transcript and protein level.
The absence of COL10A1 during chondrogenic 
differentiation of MSCs affected the ECM
After confirming the efficiency of COL10A1 knock-
down, how chondrogenic differentiation of MSCs 
was affected in its absence was investigated. For all 
donors, non-treated, empty vector and non-target 
Fig. 2. COL10A1 can be efficiently knocked-down using lentivirally delivered shRNA. MSCs were 
transduced with lentivirus containing an empty vector, non-target shRNA or COL10A1 shRNA. Then, 
MSCs were selected based on puromycin resistance, expanded and chondrogenically differentiated for 
21 d, when they were harvested for analysis. (a) Compared to control conditions, MSCs transduced with 
shRNA directed against COL10A1 showed significant down regulation of gene expression, with the level 
of knock-down varying between donors (% NT vs. COLX KD; pooled data: linear mixed model with 
Bonferonni correction: a p < 0.05). (b) This down regulation was also observed at the protein level by 
Western blot and (c) COLX immunohistochemistry. Scale bar: 200 μm. NT: non-treated; EV: empty vector; 
SC: non-target control; KD: knock-down. 
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controls maintained their chondrogenic potential, 
indicating that lentiviral transduction and RNA-
induced silencing complex activation did not 
negatively affect chondrogenic differentiation of 
MSCs (Fig. 3). COL10A1 knock-down pellets were 
significantly smaller than all controls for all donors, 
prompting the investigation of whether the absence 
of COLX affected other matrix components. When 
COLX production was mostly absent, as in donors 1 
and 2, a significant decrease in GAGs (Fig. 3b) and 
ACAN expression (Fig. 3c) was observed. However, 
when a less effective knock-down of COL10A1 
was achieved, as in donor 3, matrix production 
was less affected (Fig. 3). A similar trend was 
observed with regard to COLII at both protein (Fig. 
4a) and gene expression (Fig. 4b) level. A similar 
result was observed for COL1A1 (Fig. 4c). Overall, 
COL10A1 knock-down affected the production of 
crucial chondrogenic ECM components following 
differentiation.
A complete cartilage template was essential for 
tissue-engineered MSC-mediated EO
After observing that COL10A1 knock-down in 
MSCs affected tissue-engineered cartilage formation 
and confirming that control conditions for each 
Fig. 3. A small quantity of COL10A1 was required for the production of GAGs during chondrogenic 
differentiation of MSCs. (a) Thionine staining and GAG quantification showed that, upon over 99 % COL10A1 
knock-down, GAG production was decreased (donors 1 and 2). (b) Production of 20 % of the original COL10A1 
quantity was enough to trigger GAG production (donor 3). (c) A similar pattern was also observed for ACAN 
expression. Staining and expression of genes did not vary greatly among non-treated, empty and non-target 
conditions. Scale bar: 200 μm. NT: non-treated; EV: empty vector; SC: non-target control; KD: knock-down. 
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donor were unaffected, how a lack of COL10A1 
affected endochondral bone formation following 
subcutaneous implantation in nude mice, a model 
shown to result in endochondral bone formation 
(Farrell et al., 2011; Knuth et al., 2017), was determined. 
Chondrogenically differentiated MSC pellets 
were cultured for 21 d in vitro and implanted 
subcutaneously in nude mice. All control conditions 
from these donors underwent mineralisation (Fig. 5). 
COL10A1 knock-down pellets from donors 1 and 2 
did not show in vivo mineralisation in μCT scans (Fig. 
5b). No pellets containing COL10A1 shRNA were 
retrieved from donor 1 and only 1 of the 9 implanted 
pellets was retrieved from donor 2. This pellet 
showed calcification around the outer periphery but 
no marrow formation and was substantially smaller 
than control pellets (Fig 5a, donor 2). All pellets from 
donor 3 containing shRNA against COL10A1 not only 
provided evidence of calcification in μCT scans (Fig. 
5b; donor 3), albeit less than that observed in other 
conditions, but also after 10 weeks in vivo showed the 
presence of mature bone, bone marrow and calcified 
cartilage.
 An almost complete down-regulation of COL10A1 
in MSCs pre-implantation hindered in vivo bone 
formation; however, when down-regulation was not 
as efficient, bone formation proceed normally.
Fig. 4. A small quantity of COL10A1 was required for proper COLII production during chondrogenic 
differentiation of MSCs. (a) COLII immunohistochemistry and (b) gene expression showed that, when 
COL10A1 was knocked-down over 99 %, COL2A1 production was affected (donors 1 and 2). When the knock-
down was less efficient (donor 3), COL2A1 production was not affected. (c) The same trend was observed for 
COL1A1. Staining and expression of genes did not vary greatly between non-treated, empty and non-target 
conditions. Scale bar: 200 μm. NT: non-treated; EV: empty vector; SC: non-target control; KD: knock-down. 
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Chondrogenic matrices with decreased COL10A1 
exhibited decreased osteoclastic remodelling
As in vivo endochondral bone formation was 
differentially affected depending on the efficiency of 
COL10A1 knock-down, next step was to determine 
if the presence of osteoclasts – important for 
matrix remodelling, a central process to successful 
endochondral bone formation (Ortega et al., 2004) 
– was also affected in a similar manner. TRAP was 
performed and a different staining pattern was 
observed in donor 2 COL10A1-shRNA-containing 
pellet versus controls (Fig. 6). Non-treated, empty 
vector and scrambled pellets showed positive staining 
in the central marrow cavity whereas COL10A1-
shRNA-containing pellets only showed staining 
around the outer periphery. This was starkly different 
from COL10A1-shRNA-containing pellets from donor 
3 which exhibited a similar staining pattern to what 
was observed in all different control condition pellets 
(Fig. 6). When COL10A1 expression was significantly 
knocked-down, less osteoclasts were observed in vivo; 
however, this could be an indirect rather than direct 
effect of COL10A1 knock-down. Further research will 
be required to determine this.
Down-regulation of COL10A1 affected the secretion 
profile of chondrogenic MSCs
Following implantation, some calcification and altered 
cell recruitment were observed in COL10A1 knock-
down pellet from donor 2. Less extensive differences 
were observed in COL10A1 knock-down pellets 
from donor 3 (Fig. 7). In order to further understand 
why these differences occurred, the secreted profile 
of factors produced by chondrogenic MSCs and 
influencing EO was investigated. PDGF-BB and FGF-
2, two factors involved in endothelial migration and 
Fig. 5. When COL10A1 production was absent in chondrogenically differentiated MSCs, bone formation 
was hindered. However, a less significant knock-down resulted in normal bone formation. (a,b) Following 
8 (donors 1 and 2) or 10 weeks (donor 3) of in vivo implantation, control conditions showed the production 
of bone, bone marrow and calcified cartilage. Donor 1 COL10A1 knock-down pellets could not be retrieved 
following implantation; however, one pellet from donor 2 showed signs of mineralisation. Pellets from 
donor 3 appeared to be similar to control conditions; however, mineralisation was initially delayed, as 
observed in longitudinal μCT. Given that the samples were retrieved at 8 weeks for donors 1 and 2 and at 
10 weeks for donor 3, it was not possible to pool the donors for statistical analysis. Scale bar: 200 μm. NT: 
non-treated; EV: empty vector; SC: non-target control; KD: knock-down; n.d.: non-detectable.
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osteoblastic migration/maturation (Kim et al., 2007; 
Ornitz, 2005; Xie et al., 2014), were lowly expressed 
(Fig. 7a,b). These factors were both detected at a 
higher level in donors 2 and 3. A similar trend was 
observed for TNFα, a factor linked to inflammation 
and osteoclastic maturation (Gerstenfeld et al., 2003; 
Kimble et al., 1997) (Fig. 7c). This showed that the 
secreted profile of chondrogenically differentiated 
MSCs, at least in part, was influenced by COL10A1 
production.
Discussion
The role of COLX in EO is often debated. Where 
some developmental studies have found significant 
perinatal death, delayed bone formation and a 
compromised immune system, others have reported 
no major difference between knock-out and wild-
type controls (Jacenko et al., 2001; Jacenko et al., 2002; 
Kwan et al., 1997; Rosati et al., 1994). In these studies, 
matrix production was significantly altered, resulting 
in the distribution of matrix components around 
hypertrophic cells and throughout the growth plate 
(Jacenko et al., 2001; Jacenko et al., 2002). COLX also 
plays a role in the movement and accumulation of 
proteoglycans and associates with other collagens 
within the matrix (Chen et al., 1990; Chen et al., 1992; 
Poole and Pidoux, 1989). However, how COLX 
contributes to tissue-engineered cartilage formation 
and subsequent endochondral bone formation has 
yet to be determined. The present study investigated 
the role of COLX from a tissue engineering 
perspective using culture-expanded MSCs. Using 
chondrogenically differentiated MSCs, which are 
prone to hypertrophic differentiation (Mueller and 
Tuan, 2008; Narcisi et al., 2015; Pelttari et al., 2006), 
GAG quantity was found to be significantly decreased 
and other major ECM components, including COLII 
and aggrecan, significantly downregulated or almost 
absent when COLX knock-down was more than 80 % 
(gene expression). As chondrogenically differentiated 
MSCs express COLX early during differentiation and 
have previously been shown to form bone following 
in vivo implantation (Farrell et al., 2011; Farrell et al., 
2008; van der Stok et al., 2014), this system was a 
suitable model for the present study. Several lentiviral 
controls were included to ensure that transfection 
of primary MSCs with a lentivirus [empty vector 
control (SHC001)] and the activation of RNA-induced 
silencing complex (RISC) [by a non-target control 
shRNA (SHC002)] was not having detrimental 
effects on cell behaviour. To ensure that the proper 
concentration of protamine sulphate, puromycin 
and lentiviral supernatant were used, extensive 
testing was completed prior to experimental work 
start. This allowed to minimise unnecessary stress 
to MSCs throughout the study. In some instances, 
Fig. 6. Osteoclast activity in response to COL10A1 knock-down in chondrogenically differentiated 
MSCs following in vivo implantation was affected in relation to the efficiency of the knock-down. TRAP 
staining of implanted pellets following 8 (donors 1 and 2) or 10 (donor 3) weeks of in vivo implantation. 
Pellets containing COL10A1 shRNA could not be recovered following implantation from donor 1. 1 of 
the 9 COL10A1-shRNA-containing pellets from donor 2 was recovered but only exhibited TRAP positive 
staining on the outer periphery. All implanted pellets from donor 3 were recovered and displayed TRAP 
positivity throughout the construct. Staining did not vary greatly among non-treated, empty and non-
target conditions. Scale bar: 200 μm (bigger squares) and 50 μm (smaller squares). NT: non-treated; EV: 
empty vector; SC: non-target control; KD: knock-down.
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an increased chondrogenic potential was observed 
in lentivirally transduced cells (empty vector and 
non-target vector) as compared to non-treated MSCs. 
The addition of protamine sulphate could have 
contributed to this increase, as it has been shown to 
increase proliferation and differentiation potential 
when used in transduction protocol (Lin et al., 2012). 
Protamine sulphate was not included in non-treated 
control in order to assess the chondrogenic and bone-
forming potential of truly non-treated cells which 
had undergone the same number of passages. Given 
the extensive passaging required to accumulate the 
number of MSCs required for these experiments and 
the inherent donor variability observed in MSCs, each 
donor was shown independently in order to give a 
clear impression of the results.
 Knuth et al. (2017) observed a close relation 
between COLII and COLX, which are expressed 
almost simultaneously during early chondrogenic 
differentiation. It is possible that during chondrogenic 
differentiation of MSCs, COLX expression is essential 
for COLII and in the absence of COLX, not only is 
COLII affected, but also other ECM components which 
are essential for proper chondrogenic differentiation. 
Rosati et al. (1994), in a COL10A1 knock-down and 
Tg mouse model study, showed that adjacent non-
hypertrophic chondrocytes, which are unaffected 
by the knock-down, are still able to produce normal 
cartilage matrix components. As these non-affected 
cells were not present in the present model, this could 
explain why matrix production was more severely 
affected. Knuth et al. (2017) and Pelttari et al. (2006) 
have previously reported that COL10A1 expression 
occurs early in chondrogenic differentiation of MSCs, 
being observed within the first few days. In tissue 
engineering, it appears as if a certain threshold 
of COL10A1 production is crucial for proper 
cartilage matrix formation during chondrogenic 
differentiation. When COL10A1 was efficiently down-
regulated, proper matrix formation was hindered. 
Not only were crucial ECM components not 
produced, but the secreted profile of the constructs 
was affected. A small quantity of COL10A1 (roughly 
20 % of the original; donor 3) was sufficient to allow 
MSC construct to undergo ossification and marrow 
formation in vivo, albeit less than in non-knock-down 
conditions. This might indicate that a minimum 
threshold of COLX production allowed for these 
Fig. 7. When COL10A1 production was absent, the production of factors related to osteoclastic and 
osteoblastic migration and maturation was decreased but a small quantity rescued this effect. (a,b) 
A significant knock-down of COL10A1 was required for other factors related to osteoblastic migration 
and maturation, hPDGF-BB and hFGF-2, to be down-regulated (donor 1). A small quantity of COL10A1 
remaining in knock-down conditions showed no inhibition of hPDGF-BB and hFGF-2 (donors 2 and 3). (c) 
Production of hTNFα was down regulated when COL10A1 was downregulated in chondrogenic MSCs. 
Production did not vary greatly between non-treated, empty and non-target conditions. As donor were not 
pooled, no statistical analysis was performed. NT: non-treated; EV: empty vector; SC: non-target control; 
KD: knock-down. n.d.: not determined.
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processes to still occur. A larger number of donors 
would be helpful to determine exactly what this 
threshold is.
 Schmid type metaphyseal chondrodysplasia, a 
disease resulting in dwarfism, coxa vara and other 
skeletomuscular defects, is the result of mutated or 
deficient COLX production (Chan et al., 1998; Mcintosh 
et al., 1994; Warman et al., 1993). As a significant effect 
was observed when COLX production was decreased 
during chondrogenesis, how this affected bone 
formation following implantation was investigated. 
A severe decrease in COLX production had not 
only major consequences on MSC chondrogenic 
differentiation but also affected endochondral bone 
formation. When COLX was significantly down 
regulated, as in donor 1, bone formation was not 
observed. However, in donor 2, who also had a 
highly efficient knock-down, only one pellet from 
the implant pockets was retrieved, with calcification 
of the construct but no marrow formation. Overall, 
this donor appeared to be slightly delayed in bone 
formation, as controls had very little marrow 
formation following implantation. It is possible that 
had the in vivo time frame been increased, marrow 
formation would have occurred, but this would 
require verification by further investigation. In donor 
3, where knock-down efficiency was under 90 %, 
matrix remodelling and bone formation appeared 
relatively unaffected; however, mineralisation was 
still less than in non-treated controls. Due to the 
inherent variability in these types of experiments, 
because of inter-donor as well as lentivirus batches 
variations, it was difficult to make a clear broad 
statement on the knock-down effect in all donors. 
However, the knock-down variability enabled the 
conclusion that some degree of COLX expression 
was sufficient for bone formation to take place, since 
bone formation was only inhibited in the samples 
where COLX was knocked-down completely. It is 
possible that the greater chondrogenic potential of 
this donor required a higher lentiviral load in order 
to completely prevent COL10A1 expression due to 
the presence of more mRNA per cell. However, a 
higher virus concentration increases the risks of off-
target effects. It would be of great interest to study if 
the overexpression of COL10A1 in this model would 
improve chondrogenic differentiation or increase 
the secretion of factors which influence in vivo 
matrix remodelling and bone formation. Alternative 
knock-down approaches, for example a CRISPR-Cas 
system using hTERT-immortalised MSCs, would be 
beneficial to confirm those findings.
 To further understand these differences, the 
secretion of relevant molecules was investigated. 
During EO, recruitment and invasion of the nearby 
vasculature, initiation of osteoclast migration, 
remodelling of the cartilaginous matrix and 
osteoblastic maturation and bone deposition are all 
essential. Those processes can be initiated by different 
secreted factors (Boeuf and Richter, 2010; Scotti et al., 
2013; Scotti et al., 2010; Tonnarelli et al., 2014), which 
were released or found within the matrix of the 
implanted chondrogenic pellets. TNFα production 
was downregulated when COLX expression was 
decreased. TNFα is produced at high levels by 
hypertrophic chondrocytes (Kon et al., 2001). TNFα is 
not only a major inflammatory factor involved in bone 
fracture healing (Gerstenfeld et al., 2003) but also an 
important factor in bone formation and metabolism. It 
is involved in osteoclast differentiation and mediates 
bone turnover (Bertolini et al., 1986; Kimble et al., 1997). 
In fracture repair studies, a decreased recruitment of 
osteoclasts as well as delayed endochondral bone 
formation are observed in mice with TNFα signalling 
deficiency (Gerstenfeld et al., 2003). Other factors, 
including PDGF-BB and FGF-2, which are expressed 
consistently during all stages of fracture repair 
(Bolander, 1992), were also found to be affected by 
a lack of COLX. PDGF is important for osteoblastic 
differentiation (Li et al., 2014; Yu et al., 1997) and 
contributes to the stabilisation of blood vessels by 
orchestrating migration and assembly of pericytes, 
which contribute to proper vasculature formation 
(Caplan and Correa, 2011; Xie et al., 2014). FGFs play a 
role in EO and are also important for the proliferation 
and differentiation of chondrocytes (Kronenberg, 
2003; Ornitz and Marie, 2002). Additionally, FGFs 
play a role in osteoclast formation and maturation 
(Hurley et al., 1998; Kawaguchi et al., 2000; Nakagawa 
et al., 1999). A significant decrease in TNFα, PDGF-
BB and FGF-2 was found when COL10A1 was 
knocked-down over 99 % as compared to controls 
which did not show a difference in the production 
of this or other reported factors (donor 1). In donor 
1 COL10A1 knock-down, constructs were never 
retrieved following implantation. These constructs 
were most likely resorbed or degraded by the host. 
However, donors which had a decreased COLX 
expression but still maintained TNFα, PDGF-BB 
and FGF-2 expression were retrieved and formed 
bone following implantation (donors 2 and 3). 
In retrieved pellets from these donors, bone and 
signs of osteoclastic remodelling were observed, 
as evident by TRAP positive staining. Possibly, 
the production of these secreted factors was high 
enough to initiate the migration of osteoclasts and 
osteoblasts required to initiate bone formation. A full 
secreted profile analysis would be helpful to further 
elucidate the effects of a COL10A1 knock-down on 
the chondrogenic secretome of differentiated MSCs.
 In the present study, significant effects of COLX 
during both cartilage and bone formation, were 
observed. However, Rosati et al. (1994) found no 
major defects or skeletal abnormalities when COLX 
production is inhibited. This could be explained by 
the species’ differences, as neither mouse cells nor a 
fully immune competent environment were part of 
the present study. Additionally, it is possible that, 
in Rosati et al. (1994) study, other collagens and 
components in the ECM were able to compensate 
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for the absence of COLX by surrounding cells in the 
growth plate. As the present model was a single-cell 
culture followed by subcutaneous implantation in 
a normally non-bony environment, no such cells 
close to the construct were present to compensate 
for the lack of COLX. As is often the case with MSC 
studies, a certain amount of inter- and intra-donor 
variation was observed. Although inter-donor 
variation is well documented in MSCs, the intra-
donor variation observed could be attributed to the 
random integration nature of lentiviral delivery. 
This could have been controlled partially for by 
single-cell expansion, which is extremely difficult 
to achieve when using a primary MSC cell source. 
This variation has also been observed by others 
utilising primary MSCs (Lin et al., 2012). However, 
it is clear from a tissue engineering perspective that 
COLX is essential for proper cartilage and bone 
formation. Its presence is required for proper cartilage 
differentiation pre-implantation and necessary for 
subsequent endochondral bone formation. With this 
in mind, it could be possible to further improve graft 
performance with chondrogenically differentiated 
MSCs by over expressing or increasing hypertrophic 
differentiation pre-implantation, augmenting the 
production of important factors which are influenced 
by the presence of COLX. However, further studies 
are required to prove this. By improving the 
understanding of how these constructs achieve 
endochondral bone formation, graft performance 
and clinical relevance of such constructs will also 
improve.
Conclusion
The present study showed how the absence of 
COLX in MSCs not only hindered the ability of 
MSCs to undergo chondrogenesis but also affected 
subsequent endochondral ossification following 
in vivo implantation. From a tissue engineering 
perspective, the study improved the understanding 
of how MSC-mediated endochondral ossification is 
achieved. Understanding COLX plays a crucial role. 
The present method of bone formation could further 
improve graft construction in the future.
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Discussion with Reviewers
Daniel Kelly: COLX appeared to be important not 
only for endochondral ossification, but also for 
initiation of MSC chondrogenesis. What are the 
implications of this finding for the cartilage tissue 
engineering field and the widespread belief that 
COLX expression is always a ‘bad thing’ as it suggests 
hypertrophy? Should we also be viewing COLX as a 
key early marker of MSC chondrogenesis?
Authors: With regard to MSC-based chondrogenesis, 
we believe that COLX expression closely mirrors the 
expression of COLII and, therefore, is expressed quite 
early in chondrogenesis (Fig.1d day 7 and Knuth et al., 
2017). However, it is still not desirable in the context 
of cartilage tissue engineering as it seems to always 
precede bone formation. In healthy chondrocytes, 
COLX expression is not observed and is usually also 
seen as a marker of negative processes in the joint 
related to osteoarthritis onset and progression. We 
believe, it is valid to say that it could be a key early 
marker of MSC chondrogenesis in the currently 
available protocols for differentiation in vitro, but 
with the caveat that this chondrogenesis will most 
probably lead to endochondral ossification.
Daniel Kelly: For the donors that failed to undergo 
endochondral ossification in vivo, it is difficult to link 
this directly to the absence of COLX, as, in general, 
chondrogenesis and ECM accumulation were also 
supressed in these groups. In the future, might it be 
possible to silence COL10A1 later in chondrogenesis 
to better elucidate its role in hypertrophy and 
endochondral ossification?
Authors: This would involve generating a lentivirus 
with an extra inducible cassette that enables 
overexpression of the shRNA for COL10A1 when a 
specific antibiotic is added to the culture medium. 
Theoretically, this would enable the knock-down of 
the gene from a specific time point or for a desired 
duration. However, there would be some technical 
issues to overcome. For example, these systems can 
be very leaky, leading to some expression of the 
shRNA even without the addition of the specific 
inducer. Also, penetration of the antibiotic through 
the dense matrix of the chondrogenic pellet would 
have to be assessed and verified. In general, it would 
be very interesting to assess if there is a stage specific 
necessity for COL10A1 expression.
Editor’s note: The Scientific Editor responsible for 
this paper was Martin Stoddart.
